Functional Tumor Necrosis Factor--Related Apoptosis-Inducing Ligand Production by Avian Influenza Virus--Infected Macrophages

Jianfang Zhou; Law, Helen K. W.; Chung Yan Cheung; Ng, Iris H. Y.; Peiris, J. S. Malik; Yu Lung Lau
April 2006
Journal of Infectious Diseases;4/1/2006, Vol. 193 Issue 7, p945
Academic Journal
Severe human disease associated with influenza A H5N1 virus was first detected in Hong Kong in 1997. Its recent reemergence in Asia and high associated mortality highlight the need to understand its pathogenesis. We investigated the roles of death receptor ligands (DRLs) in H5N1 infection. Significant up-regulation of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-α, but not Fas ligand (FasL) mRNA, was detected in human monocyte-derived macrophages (MDMs) infected with avian influenza viruses A/Hong Kong/483/97 (H5N1/97) or its precursor, A/Quail/Hong Kong/G1/97. H5N1/97-infected MDMs exhibited the strongest induction of apoptosis in Jurkat T cells, and it could be reduced by TRAIL-receptor 2 blocking antibody. Furthermore, influenza virus infection enhanced the sensitivity of Jurkat T cells to apoptosis induced by TNF-α, TRAIL, and FasL. Our data suggested that functional TRAIL produced by influenza virus- infected MDMs was related to their cytotoxicity and that the enhanced sensitization to DRL-induced apoptosis detected in avian influenza may contribute to disease pathogenesis.


Related Articles

  • Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Fulda, Simone; Jeremias, Irmela; Debatin, Klaus-Michael // Oncogene;10/7/2004, Vol. 23 Issue 46, p7611 

    We previously reported that the TRAIL (tumor necrosis factor (TNF)-related apoptosis-inducing ligand)-induced death signal requires amplification by mitochondria in certain cell types, for example, in type II cells. Here, we provide for the first time evidence that the natural compound betulinic...

  • Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells. Huang, H.-L.; Yeh, W.-C.; Lai, M.-Z.; Mirtsos, C.; Chau, H.; Chou, C.-H.; Benchimol, S. // British Journal of Cancer;11/3/2009, Vol. 101 Issue 9, p1555 

    Background: Tumour necrosis factor (TNF) is capable of activating the cell death pathway, and has been implicated in killing transformed cells. However, TNF also activates survival signals, including NF-kappaB activation and the subsequent expression of anti-apoptotic genes, leading...

  • Luteolin sensitizes tumor necrosis factor-a-induced apoptosis in human tumor cells. Shi, Ran-Xin; Ong, Choon-Nam; Shen, Han-Ming // Oncogene;10/7/2004, Vol. 23 Issue 46, p7712 

    Tumor necrosis factor-a(TNFa) activates both cell death and cell survival pathways, which render most cancer cells resistant to its cytotoxicity. In this study, we found that pretreatment with luteolin, a plant flavonoid, greatly sensitized TNFa-induced apoptotic cell death in a number of human...

  • Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic? Daniel, D.; Wilson, N. S. // Current Cancer Drug Targets;Mar2008, Vol. 8 Issue 2, p124 

    Since the discovery of tumor necrosis factor (TNF)-alpha, researchers have pursued many approaches to harness the potency of TNF-alpha and TNF superfamily members to treat human cancers. Several ligands of the TNF superfamily, including TNF-alpha, lymphotoxin, FAS ligand (FasL), and APO2...

  • Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Simmons, M. J.; Fan, G.; Zong, W.-X.; Degenhardt, K.; White, E.; Gélinas, C. // Oncogene;2/28/2008, Vol. 27 Issue 10, p1421 

    The prosurvival Bcl-2-family member Bfl-1/A1 is a transcriptional target of nuclear factor-κB (NF-κB) that is overexpressed in many human tumors and is a means by which NF-κB inhibits apoptosis, but its mode of action is controversial. To better understand how Bfl-1 functions, we...

  • Sequence-based discovery of a synthetic peptide inhibitor of caspase 6. Nyormoi, O.; Wang, Z.; Bar-Eli, M. // Apoptosis;Aug2003, Vol. 8 Issue 4, p371 

    We recently demonstrated that tumor necrosis factor alpha activates caspase 6, which in turn cleaves transcription factor AP-2 alpha. We mapped the cleavage site at 19 amino acids from the N-terminus at the sequence aspartate-argenine-histidine-aspartate (DRHD). Mutating aspartic acid at...

  • On the TRAIL of a new therapy for leukemia. Kaufmann, S.H.; Steensma, D.P. // Leukemia (08876924);Dec2005, Vol. 19 Issue 12, p2195 

    The cytokine TRAIL (tumor necrosis factor alpha-related apoptosis-inducing ligand) as well as agonistic antibodies that bind to the TRAIL receptors, death receptor 4 (DR4) and DR5, are undergoing preclinical and early clinical evaluation as potential therapeutic agents for a variety of...

  • Ubiquitin-proteasome pathway as a primary defender against TRAIL-mediated cell death. Kim, S.; Choi, K.; Kwon, D.; Benveniste, E. N.; Choi, C. // Cellular & Molecular Life Sciences;Apr2004, Vol. 61 Issue 9, p1075 

    Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptotic cell death as well as expression of proinflammatory genes such as CXCL8 in malignant human astrocytoma cells. However, the molecular mechanisms that determine the fate of cells are not yet understood. The ubiquitin...

  • Apoptosis and HIV Infection: About Molecules and Genes. Cossarizza, Andrea // Current Pharmaceutical Design;Jan2008, Vol. 14 Issue 3, p237 

    During the evolution, the immune system has developed several strategies to fight viral infections. Apoptosis, autophagy and necrosis are different types of cell death that play a main role in the interactions between infective agents and the host, since they are often important defence...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics